Vanguard Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Hold |
|
|||||
|
2025
Q1 | $1.13M | Buy |
|
|||||
|
2024
Q4 | $2.38M | Sell |
|
|||||
|
2024
Q3 | $1.47M | Buy |
|
|||||
|
2024
Q2 | $1.44M | Sell |
|
|||||
|
2024
Q1 | $3.48M | Sell |
|
|||||
|
2023
Q4 | $3.43M | Buy |
|
|||||
|
2023
Q3 | $9.78M | Sell |
|
|||||
|
2023
Q2 | $11.2M | Buy |
|
|||||
|
2023
Q1 | $19.9M | Sell |
|
|||||
|
2022
Q4 | $23.7M | Buy |
|
|||||
|
2022
Q3 | $25M | Sell |
|
|||||
|
2022
Q2 | $56.9M | Buy |
|
|||||
|
2022
Q1 | $64.2M | Sell |
|
|||||
|
2021
Q4 | $112M | Buy |
|
|||||
|
2021
Q3 | $122M | Buy |
|
|||||
|
2021
Q2 | $104M | Buy |
|
|||||
|
2021
Q1 | $91.2M | Buy |
|
|||||
|
2020
Q4 | $111M | Buy |
|
|||||
|
2020
Q3 | $62.2M | Buy |
|
|||||
|
2020
Q2 | $67.6M | Buy |
|
|||||
|
2020
Q1 | $32.5M | Buy |
|
|||||
|
2019
Q4 | $60.6M | Buy |
|
|||||
|
2019
Q3 | $50.6M | Buy |
|
|||||
|
2019
Q2 | $60.6M | Buy |
|
|||||
|
2019
Q1 | $114M | Buy |
|
|||||
|
2018
Q4 | $97.8M | Buy |
|
|||||
|
2018
Q3 | $103M | Buy |
|
|||||
|
2018
Q2 | $87.5M | Buy |
|
|||||
|
2018
Q1 | $61.7M | Buy |
|
|||||
|
2017
Q4 | $17M | Buy |
|
|||||
|
2017
Q3 | $15.2M | Buy |
|
|||||
|
2017
Q2 | $11.8M | Buy |
|
|||||
|
2017
Q1 | $17.1M | Buy |
|
|||||
|
2016
Q4 | $10.7M | Buy |
|
|||||
|
2016
Q3 | $15M | Buy |
|
|||||
|
2016
Q2 | $15.3M | Buy |
|
|||||
|
2016
Q1 | $10.8M | Sell |
|
|||||
|
2015
Q4 | $15.4M | Buy |
|
|||||
|
2015
Q3 | $17.9M | Buy |
|
|||||
|
2015
Q2 | $18.6M | Buy |
|
|||||
|
2015
Q1 | $9M | Buy |
|
|||||
|
2014
Q4 | $3.45M | Buy |
|